FDA Roundup: March 22, 2024
FDA Roundup: March 19, 2024
FDA Roundup: March 19, 2024
Ascension disclosed Wednesday that it has detected “unusual activity” on some of its technology networks that it believes “is due to a cybersecurity event.” |…
Patients say the device allows them to reduce the number of hospital visits involved in cancer care.
As many conservatives hail the fall of Roe for saving unborn lives, high-risk pregnancy becomes even more perilous.
The law prohibits telehealth appointments for abortion, but some groups are already using out-of-state physicians to prescribe the necessary medications.
This report discusses three cases of extrapulmonary Myocobacterium abscessus infections associated with stem cell treatment clinics in Mexico.
The monthly Cancer Prevention Works newsletter provides the latest information about activities and accomplishments in CDC’s Division of Cancer Prevention and Control.
The U.S. drug regulator has pushed back its decision on Moderna’s respiratory syncytial virus (RSV) vaccine due to “administrative constraints” and will complete the review…
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
prostate cancer, advanced prostate cancer, androgen deprivation therapy (ADT), Relugolix, Dosing of Relugolix, gonadotropin-releasing hormone (GnRH) receptor antagonist, HERO study, abiraterone acetate, apalutamide, metastatic castration-sensitive…